Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Peter Stephen Conti, MD, PhD

    TitleProfessor of Radiology
    SchoolKeck School of Medicine of USC
    DepartmentRadiology
    AddressCSC 103
    Health Sciences Campus
    Los Angeles California 90089-9062
    Phone+1 323 442 3858
    vCardDownload vCard
      Other Positions
      TitleDirector, Molecular Imaging Center

      TitlePet Imaging Center Director


      Collapse Overview 
      Collapse Overview
      Dr. Conti completed his MD at Cornell University Medical College and then went on to Cornell University Graduate School of Medicine to do his Ph.D. in Biophysics. After an Internship in Surgery at St. Lukes Hospital, NY he went on to do his residency in Radiology, and then a fellowship in Nuclear Medicine at John Hopkins Hospital, MD. He joined the staff at USC as a professor of Pharmacy and then Radiology and Biomedical Engineering. Dr. Conti as board certification from the the American Board of Radiology and American Board of Nuclear Medicine.


      Collapse Biography 
      Collapse Clinical Trials

      Collapse ORNG Applications 
      Collapse Websites
      Collapse Required Scholarly Project Mentor

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Jadvar H, Park R, Yap LP, Chen K, Hughes L, Conti P. Effect of Androgen on Normal Biodistribution of [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice. Anticancer Res. 2017 02; 37(2):475-479. PMID: 28179292.
        View in: PubMed
      2. Wang J, Chen F, Arconada-Alvarez SJ, Hartanto J, Yap LP, Park R, Wang F, Vorobyova I, Dagliyan G, Conti P, Jokerst JV. A Nanoscale Tool for Photoacoustic-Based Measurements of Clotting Time and Therapeutic Drug Monitoring of Heparin. Nano Lett. 2016 Sep 28. PMID: 27668964.
        View in: PubMed
      3. Huang R, Conti P, Chen K. In Vivo Tumor Angiogenesis Imaging Using Peptide-Based Near-Infrared Fluorescent Probes. Methods Mol Biol. 2016; 1444:73-84. PMID: 27283419.
        View in: PubMed
      4. Fang J, Xiao L, Joo KI, Liu Y, Zhang C, Liu S, Conti P, Li Z, Wang P. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice. Int J Cancer. 2016 Feb 15; 138(4):1013-23. PMID: 26334777.
        View in: PubMed
      5. Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, Di Biase S, Mirzaei H, Mirisola MG, Childress P, Ji L, Groshen S, Penna F, Odetti P, Perin L, Conti P, Ikeno Y, Kennedy BK, Cohen P, Morgan TE, Dorff TB, Longo VD. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metab. 2015 Jul 7; 22(1):86-99. PMID: 26094889.
        View in: PubMed
      6. Conti P. In Memoriam: Walter Wolf, PhD, 1931-2014. J Nucl Med. 2015 May; 56(5):13N. PMID: 25934677.
        View in: PubMed
      7. Wang H, Li D, Liu S, Liu R, Yuan H, Krasnoperov V, Shan H, Conti P, Gill PS, Li Z. Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159. J Nucl Med. 2015 Jun; 56(6):908-13. PMID: 25908833.
        View in: PubMed
      8. Jadvar H, Challa S, Quinn DI, Conti P. One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer. Cancer Biother Radiopharm. 2015 Jun; 30(5):195-9. PMID: 25746633.
        View in: PubMed
      9. Selvaraj R, Giglio B, Liu S, Wang H, Wang M, Yuan H, Chintala SR, Yap LP, Conti P, Fox JM, Li Z. Improved Metabolic Stability for (18)F PET Probes Rapidly Constructed via Tetrazine trans-Cyclooctene Ligation. Bioconjug Chem. 2015 Mar 18; 26(3):435-42. PMID: 25679331.
        View in: PubMed
      10. Jadvar H, Desai B, Conti P. Sodium 18F-fluoride PET/CT of bone, joint, and other disorders. Semin Nucl Med. 2015 Jan; 45(1):58-65. PMID: 25475379.
        View in: PubMed
      11. Huang R, Wang M, Zhu Y, Conti P, Chen K. Development of PET Probes for Cancer Imaging. Curr Top Med Chem. 2015; 15(8):795-819. PMID: 25732787.
        View in: PubMed
      12. Ma W, Li G, Wang J, Yang W, Zhang Y, Conti P, Chen K. In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature. Amino Acids. 2014 Dec; 46(12):2721-32. PMID: 25182731.
        View in: PubMed
      13. Li D, Liu S, Liu R, Park R, Yu H, Krasnoperov V, Gill PS, Li Z, Shan H, Conti P. Axl-Targeted Cancer Imaging with Humanized Antibody h173. Mol Imaging Biol. 2014 Aug; 16(4):511-8. PMID: 24424460.
        View in: PubMed
      14. Hu LY, Bauer N, Knight LM, Li Z, Liu S, Anderson CJ, Conti P, Sutcliffe JL. Characterization and Evaluation of (64)Cu-Labeled A20FMDV2 Conjugates for Imaging the Integrin avß 6. Mol Imaging Biol. 2014 Aug; 16(4):567-77. PMID: 24448825.
        View in: PubMed
      15. Li G, Wang X, Zong S, Wang J, Conti P, Chen K. MicroPET Imaging of CD13 Expression Using a (64)Cu-Labeled Dimeric NGR Peptide Based on Sarcophagine Cage. Mol Pharm. 2014 Nov 3; 11(11):3938-46. PMID: 25054774.
        View in: PubMed
      16. Hu H, Li D, Liu S, Wang M, Moats R, Conti P, Li Z. Integrin a2ß1 targeted GdVO4:Eu ultrathin nanosheet for multimodal PET/MR imaging. Biomaterials. 2014 Oct; 35(30):8649-58. PMID: 25043573.
        View in: PubMed
      17. Liu S, Li D, Guo J, Canale N, Li X, Liu R, Krasnoperov V, Gill PS, Conti P, Shan H, Li Z. Design, Synthesis, and Validation of Axl-Targeted Monoclonal Antibody Probe for microPET Imaging in Human Lung Cancer Xenograft. Mol Pharm. 2014 Nov 3; 11(11):3974-9. PMID: 24978094.
        View in: PubMed
      18. Janib SM, Gustafson JA, Minea RO, Swenson SD, Liu S, Pastuszka MK, Lock LL, Cui H, Markland FS, Conti P, Li Z, MacKay JA. Multimeric disintegrin protein polymer fusions that target tumor vasculature. Biomacromolecules. 2014 Jul 14; 15(7):2347-58. PMID: 24871936.
        View in: PubMed
      19. Liu S, Li D, Zhang Z, Surya Prakash GK, Conti P, Li Z. Efficient synthesis of fluorescent-PET probes based on [(18)F]BODIPY dye. Chem Commun (Camb). 2014 Jun 12; 50(55):7371-3. PMID: 24869927.
        View in: PubMed
      20. Wu Z, Liu S, Nair I, Omori K, Scott S, Todorov I, Shively JE, Conti P, Li Z, Kandeel F. (64)Cu Labeled Sarcophagine Exendin-4 for MicroPET Imaging of Glucagon like Peptide-1 Receptor Expression. Theranostics. 2014; 4(8):770-7. PMID: 24955138.
        View in: PubMed
      21. Wu Z, Li L, Liu S, Yakushijin F, Yakushijin K, Horne D, Conti P, Li Z, Kandeel F, Shively JE. Facile Preparation of a Thiol-Reactive 18F-Labeling Agent and Synthesis of 18F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor. J Nucl Med. 2014 Jul; 55(7):1178-84. PMID: 24854793.
        View in: PubMed
      22. Liu S, Li Z, Conti P. Development of multi-functional chelators based on sarcophagine cages. Molecules. 2014; 19(4):4246-55. PMID: 24705567.
        View in: PubMed
      23. Zhu W, Li Q, Bai B, Conti P, Leahy RM. Patlak Image Estimation From Dual Time-Point List-Mode PET Data. IEEE Trans Med Imaging. 2014 Apr; 33(4):913-24. PMID: 24710160.
        View in: PubMed
      24. Li G, Xing Y, Wang J, Conti P, Chen K. Near-infrared fluorescence imaging of CD13 receptor expression using a novel Cy5.5-labeled dimeric NGR peptide. Amino Acids. 2014 Jun; 46(6):1547-56. PMID: 24652439.
        View in: PubMed
      25. Aluri SR, Shi P, Gustafson JA, Wang W, Lin YA, Cui H, Liu S, Conti P, Li Z, Hu P, Epstein AL, Mackay JA. A hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibody. ACS Nano. 2014 Mar 25; 8(3):2064-76. PMID: 24484356.
        View in: PubMed
      26. Fei L, Yap LP, Conti P, Shen WC, Zaro JL. Tumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide. Biomaterials. 2014 Apr; 35(13):4082-7. PMID: 24508076.
        View in: PubMed
      27. Xing Y, Zhao J, Conti P, Chen K. Radiolabeled nanoparticles for multimodality tumor imaging. Theranostics. 2014; 4(3):290-306. PMID: 24505237.
        View in: PubMed
      28. Mortimer JE, Bading JR, Colcher DM, Conti P, Frankel PH, Carroll MI, Tong S, Poku E, Miles JK, Shively JE, Raubitschek AA. Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET. J Nucl Med. 2014 Jan; 55(1):23-9. PMID: 24337604.
        View in: PubMed
      29. Li D, Liu S, Liu R, Zhou Y, Park R, Naga K, Krasnoperov V, Gill PS, Li Z, Shan H, Conti P. EphB4-Targeted Imaging with Antibody h131, h131-F(ab')2 and h131-Fab. Mol Pharm. 2013 Dec 2; 10(12):4527-33. PMID: 24147882.
        View in: PubMed
      30. Lin Y, Haldar J, Li Q, Conti P, Leahy R. Sparsity Constrained Mixture Modeling for the Estimation of Kinetic Parameters in Dynamic PET. IEEE Trans Med Imaging. 2013 Nov 7. PMID: 24216681.
        View in: PubMed
      31. Jang JK, Khawli LA, Park R, Wu BW, Li Z, Canter D, Conti P, Epstein AL. Cytoreductive Chemotherapy Improves the Biodistribution of Antibodies Directed against Tumor Necrosis in Murine Solid Tumor Models. Mol Cancer Ther. 2013 Dec; 12(12):2827-36. PMID: 24130055.
        View in: PubMed
      32. Liu S, Li D, Shan H, Gabbaï FP, Li Z, Conti P. Evaluation of (18)F-labeled BODIPY dye as potential PET agents for myocardial perfusion imaging. Nucl Med Biol. 2014 Jan; 41(1):120-6. PMID: 24210284.
        View in: PubMed
      33. Bai B, Bading J, Conti P. Tumor quantification in clinical positron emission tomography. Theranostics. 2013; 3(10):787-801. PMID: 24312151.
        View in: PubMed
      34. Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, Krasnoperov V, Dong D, Liu S, Li D, Zhu G, Louie S, Conti P, Li Z, Lee AS, Gill PS. Monoclonal Antibody against Cell Surface GRP78 as a Novel Agent in Suppressing PI3K/AKT Signaling, Tumor Growth, and Metastasis. Clin Cancer Res. 2013 Dec 15; 19(24):6802-11. PMID: 24048331.
        View in: PubMed
      35. Li D, Liu S, Shan H, Conti P, Li Z. Urokinase plasminogen activator receptor (uPAR) targeted nuclear imaging and radionuclide therapy. Theranostics. 2013; 3(7):507-15. PMID: 23843898.
        View in: PubMed
      36. Jadvar H, Desai B, Ji L, Conti P, Dorff TB, Groshen SG, Pinski JK, Quinn DI. Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer. J Nucl Med. 2013 Aug; 54(8):1195-201. PMID: 23785174.
        View in: PubMed
      37. Liu S, Li D, Park R, Liu R, Xia Z, Guo J, Krasnoperov V, Gill PS, Li Z, Shan H, Conti P. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies. J Nucl Med. 2013 Jul; 54(7):1094-100. PMID: 23667241.
        View in: PubMed
      38. Liu S, Hassink M, Selvaraj R, Yap LP, Park R, Wang H, Chen X, Fox JM, Li Z, Conti P. Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation. Mol Imaging. 2013 Mar-Apr; 12(2):121-8. PMID: 23415400.
        View in: PubMed
      39. Liu S, Lin TP, Li D, Leamer L, Shan H, Li Z, Gabbaï FP, Conti P. Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging. Theranostics. 2013; 3(3):181-9. PMID: 23471211.
        View in: PubMed
      40. Cai H, Conti P. RGD-based PET tracers for imaging receptor integrin av ß3 expression. J Labelled Comp Radiopharm. 2013 May 15; 56(5):264-79. PMID: 24285371.
        View in: PubMed
      41. Joo KI, Xiao L, Liu S, Liu Y, Lee CL, Conti P, Wong MK, Li Z, Wang P. Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs. Biomaterials. 2013 Apr; 34(12):3098-109. PMID: 23375392.
        View in: PubMed
      42. Wu Z, Liu S, Hassink M, Nair I, Park R, Li L, Todorov I, Fox JM, Li Z, Shively JE, Conti P, Kandeel F. Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets. J Nucl Med. 2013 Feb; 54(2):244-51. PMID: 23297075.
        View in: PubMed
      43. Liu S, Park R, Conti P, Li Z. "Kit like" (18)F labeling method for synthesis of RGD peptide-based PET probes. Am J Nucl Med Mol Imaging. 2013; 3(1):97-101. PMID: 23342304.
        View in: PubMed
      44. Li D, Liu S, Liu R, Park R, Hughes L, Krasnoperov V, Gill PS, Li Z, Shan H, Conti P. Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring. Mol Pharm. 2013 Jan 7; 10(1):329-36. PMID: 23211050.
        View in: PubMed
      45. Chen K, Ma W, Li G, Wang J, Yang W, Yap LP, Hughes LD, Park R, Conti P. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression. Mol Pharm. 2013 Jan 7; 10(1):417-27. PMID: 23190134.
        View in: PubMed
      46. Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti P. Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment. Mol Imaging Biol. 2012 Dec; 14(6):718-24. PMID: 22476968.
        View in: PubMed
      47. Huang CW, Li Z, Conti P. Radioactive smart probe for potential corrected matrix metalloproteinase imaging. Bioconjug Chem. 2012 Nov 21; 23(11):2159-67. PMID: 23025637.
        View in: PubMed
      48. Chen K, Wang X, Lin WY, Shen CK, Yap LP, Hughes LD, Conti P. Strain-Promoted Catalyst-Free Click Chemistry for Rapid Construction of (64)Cu-Labeled PET Imaging Probes. ACS Med Chem Lett. 2012 Dec 13; 3(12):1019-23. PMID: 24900423.
        View in: PubMed
      49. Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, Conti P, Chen TC, Longo VD. Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One. 2012; 7(9):e44603. PMID: 22984531.
        View in: PubMed
      50. Jadvar H, Yap LP, Park R, Li Z, Chen K, Hughes L, Kouhi A, Conti P. [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations. Mol Imaging. 2012 Sep-Oct; 11(5):426-32. PMID: 22954187.
        View in: PubMed
      51. Jadvar H, Desai B, Ji L, Conti P, Dorff TB, Groshen SG, Gross ME, Pinski JK, Quinn DI. Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer. Clin Nucl Med. 2012 Jul; 37(7):637-43. PMID: 22691503.
        View in: PubMed
      52. Ley EJ, Clond MA, Bukur M, Park R, Chervonski M, Dagliyan G, Margulies DR, Lyden PD, Conti P, Salim A. ß-Adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury. J Trauma Acute Care Surg. 2012 Jul; 73(1):33-40. PMID: 22743370.
        View in: PubMed
      53. Liu S, Li D, Huang CW, Yap LP, Park R, Shan H, Li Z, Conti P. The efficient synthesis and biological evaluation of novel bi-functionalized sarcophagine for (64)cu radiopharmaceuticals. Theranostics. 2012; 2(6):589-96. PMID: 22737194.
        View in: PubMed
      54. Ng TS, Bading JR, Park R, Sohi H, Procissi D, Colcher D, Conti P, Cherry SR, Raubitschek AA, Jacobs RE. Quantitative, Simultaneous PET/MRI for Intratumoral Imaging with an MRI-Compatible PET Scanner. J Nucl Med. 2012 Jul; 53(7):1102-9. PMID: 22661534.
        View in: PubMed
      55. Chen K, Li Z, Conti P. Microwave-assisted one-pot radiosynthesis of 2'-deoxy-2'-[(18)F]fluoro-5-methyl-1-ß-d-arabinofuranosyluracil ([(18)F]-FMAU). Nucl Med Biol. 2012 Oct; 39(7):1019-25. PMID: 22503457.
        View in: PubMed
      56. Chen K, Sun X, Niu G, Ma Y, Yap LP, Hui X, Wu K, Fan D, Conti P, Chen X. Evaluation of (64)Cu Labeled GX1: A Phage Display Peptide Probe for PET Imaging of Tumor Vasculature. Mol Imaging Biol. 2012 Feb; 14(1):96-105. PMID: 21360213.
        View in: PubMed
      57. Sahu D, Zhao Z, Tsen F, Cheng CF, Park R, Situ AJ, Dai J, Eginli A, Shams S, Chen M, Ulmer TS, Conti P, Woodley DT, Li W. A potentially common peptide target in secreted heat shock protein-90a for hypoxia-inducible factor-1a-positive tumors. Mol Biol Cell. 2012 Feb; 23(4):602-13. PMID: 22190738.
        View in: PubMed
      58. Li D, Shan H, Conti P, Li Z. PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5). Am J Nucl Med Mol Imaging. 2012; 2(1):29-32. PMID: 23133800.
        View in: PubMed
      59. Li Z, Jin Q, Huang C, Dasa S, Chen L, Yap LP, Liu S, Cai H, Park R, Conti P. Trackable and Targeted Phage as Positron Emission Tomography (PET) Agent for Cancer Imaging. Theranostics. 2011; 1:371-80. PMID: 22211143.
        View in: PubMed
      60. Huang CW, Li Z, Conti P. In Vivo Near-Infrared Fluorescence Imaging of Integrin a2ß1 in Prostate Cancer with Cell-Penetrating-Peptide-Conjugated DGEA Probe. J Nucl Med. 2011 Dec; 52(12):1979-86. PMID: 22065876.
        View in: PubMed
      61. Liu S, Li Z, Yap LP, Huang CW, Park R, Conti P. Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticals. Chemistry. 2011 Sep 5; 17(37):10222-5. PMID: 21815227.
        View in: PubMed
      62. Li Z, Lin TP, Liu S, Huang CW, Hudnall TW, Gabbaï FP, Conti P. Rapid aqueous [18F]-labeling of a bodipy dye for positron emission tomography/fluorescence dual modality imaging. Chem Commun (Camb). 2011 Sep 7; 47(33):9324-6. PMID: 21779546.
        View in: PubMed
      63. Graham M, Conti P, Hoffman J. SNM clinical trials network validates 100th scanner. J Nucl Med. 2011 Jun; 52(6):25N. PMID: 21622892.
        View in: PubMed
      64. Selvaraj R, Liu S, Hassink M, Huang CW, Yap LP, Park R, Fox JM, Li Z, Conti P. Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin avß3 targeted PET tracer based on a cyclic RGD peptide. Bioorg Med Chem Lett. 2011 Sep 1; 21(17):5011-4. PMID: 21601452.
        View in: PubMed
      65. Zissen MH, Kunz P, Subbarayan M, Chin FT, Conti P, Fisher GA, Quon A. 18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases. Nucl Med Commun. 2011 May; 32(5):343-7. PMID: 21412178.
        View in: PubMed
      66. Huang CW, Li Z, Cai H, Shahinian T, Conti P. Novel a(2)ß(1) integrin-targeted peptide probes for prostate cancer imaging. Mol Imaging. 2011 Aug; 10(4):284-94. PMID: 21486537.
        View in: PubMed
      67. Cai H, Li Z, Conti P. The improved syntheses of 5-substituted 2'-[18F]fluoro-2'-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-pot strategy. Nucl Med Biol. 2011 Jul; 38(5):659-66. PMID: 21718941.
        View in: PubMed
      68. Huang CW, Li Z, Cai H, Chen K, Shahinian T, Conti P. Design, synthesis and validation of integrin a2ß1-targeted probe for microPET imaging of prostate cancer. Eur J Nucl Med Mol Imaging. 2011 Jul; 38(7):1313-22. PMID: 21350963.
        View in: PubMed
      69. Huang CW, Li Z, Cai H, Shahinian T, Conti P. Biological stability evaluation of the a2ß1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide. Bioconjug Chem. 2011 Feb 16; 22(2):256-63. PMID: 21244039.
        View in: PubMed
      70. Chen K, Yap LP, Park R, Hui X, Wu K, Fan D, Chen X, Conti P. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice. Amino Acids. 2012 Apr; 42(4):1329-37. PMID: 21212998.
        View in: PubMed
      71. Binns DS, Pirzkall A, Yu W, Callahan J, Mileshkin L, Conti P, Scott AM, Macfarlane D, Fine BM, Hicks RJ. Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2011 Apr; 38(4):642-50. PMID: 21207024.
        View in: PubMed
      72. Cai H, Li Z, Huang CW, Park R, Conti P. 64Cu Labeled AmBaSar-RGD2 for micro-PET Imaging of Integrin avß3 Expression. Curr Radiopharm. 2011 Jan 1; 4(1):68-74. PMID: 22191616.
        View in: PubMed
      73. Li Z, Cai H, Conti P. Improved Synthesis of 2'-deoxy-2'-[18F]fluoro-5-Methyl-1-ß-DArabinofuranosyluracil ([18F]FMAU). Curr Radiopharm. 2011 Jan 1; 4(1):24-30. PMID: 22191612.
        View in: PubMed
      74. Li Z, Cai H, Conti P. Automated synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-ß-D-arabinofuranosyluracil ([18F]-FMAU) using a one reactor radiosynthesis module. Nucl Med Biol. 2011 Feb; 38(2):201-6. PMID: 21315275.
        View in: PubMed
      75. Graham M, Conti P, Hoffman J. Clinical trials network strives for standardization. J Nucl Med. 2010 Nov; 51(11):15N. PMID: 21051645.
        View in: PubMed
      76. Li Z, Cai H, Hassink M, Blackman ML, Brown RC, Conti P, Fox JM. Tetrazine-trans-cyclooctene ligation for the rapid construction of 18F labeled probes. Chem Commun (Camb). 2010 Nov 14; 46(42):8043-5. PMID: 20862423.
        View in: PubMed
      77. Chen K, Conti P. Target-specific delivery of peptide-based probes for PET imaging. Adv Drug Deliv Rev. 2010 Aug 30; 62(11):1005-22. PMID: 20851156.
        View in: PubMed
      78. Li Z, Conti P. Radiopharmaceutical chemistry for positron emission tomography. Adv Drug Deliv Rev. 2010 Aug 30; 62(11):1031-51. PMID: 20854860.
        View in: PubMed
      79. Cai H, Li Z, Huang CW, Shahinian AH, Wang H, Park R, Conti P. Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression. Bioconjug Chem. 2010 Aug 18; 21(8):1417-24. PMID: 20666401.
        View in: PubMed
      80. Lacruz RS, Nanci A, White SN, Wen X, Wang H, Zalzal SF, Luong VQ, Schuetter VL, Conti P, Kurtz I, Paine ML. The sodium bicarbonate cotransporter (NBCe1) is essential for normal development of mouse dentition. J Biol Chem. 2010 Aug 6; 285(32):24432-8. PMID: 20529845.
        View in: PubMed
      81. Ley EJ, Park R, Dagliyan G, Palestrant D, Miller CM, Conti P, Margulies DR, Salim A. In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury. J Trauma. 2010 Feb; 68(2):353-6. PMID: 20154548.
        View in: PubMed
      82. Cai H, Li Z, Huang CW, Park R, Shahinian AH, Conti P. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals. Nucl Med Biol. 2010 Jan; 37(1):57-65. PMID: 20122669.
        View in: PubMed
      83. Li Z, Li Q, Pantazis D, Yu X, Conti P, Leahy RM. Controlling familywise error rate for matched subspace detection in dynamic FDG PET. IEEE Trans Med Imaging. 2009 Oct; 28(10):1623-31. PMID: 19783499.
        View in: PubMed
      84. McEwan AS, Graham MM, Conti P. Site qualification in multicenter clinical trials. J Nucl Med. 2009 Aug; 50(8):30N. PMID: 19652215.
        View in: PubMed
      85. Cai H, Fissekis J, Conti P. Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and (64)Cu radiolabelling. Dalton Trans. 2009 Jul 21; (27):5395-400. PMID: 19565091.
        View in: PubMed
      86. McEwan AS, Graham MM, Conti P. SNM molecular imaging summit introduces clinical trials network. J Nucl Med. 2009 Apr; 50(4):18N. PMID: 19339670.
        View in: PubMed
      87. Li Z, Li Q, Yu X, Conti P, Leahy RM. Lesion detection in dynamic FDG-PET using matched subspace detection. IEEE Trans Med Imaging. 2009 Feb; 28(2):230-40. PMID: 19188110.
        View in: PubMed
      88. Ley EJ, Scehnet J, Park R, Schroff S, Dagliyan G, Conti P, Margulies DR, Salim A. The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. J Trauma. 2009 Jan; 66(1):154-9; discussion 159-61. PMID: 19131818.
        View in: PubMed
      89. Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti P. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma. Oncologist. 2009; 14 Suppl 2:30-40. PMID: 19819922.
        View in: PubMed
      90. Bischof Delaloye A, Conti P, Gisselbrecht C, Gregory SA. New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Summary. Oncologist. 2009; 14 Suppl 2:52-4. PMID: 19819924.
        View in: PubMed
      91. Bischof Delaloye A, Conti P, Gisselbrecht C, Gregory SA. New directions in the therapeutic strategy to improve survival outcomes in patients with non-Hodgkin's lymphoma. Introduction. Oncologist. 2009; 14 Suppl 2:1-3. PMID: 19819919.
        View in: PubMed
      92. Jadvar H, Ye W, Groshen S, Conti P. [F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland. Ann Nucl Med. 2008 Nov; 22(9):787-93. PMID: 19039557.
        View in: PubMed
      93. Wen X, Zou Y, Luo W, Goldberg M, Moats R, Conti P, Snead ML, Paine ML. Biglycan overexpression on tooth enamel formation in transgenic mice. Anat Rec (Hoboken). 2008 Oct; 291(10):1246-53. PMID: 18727043.
        View in: PubMed
      94. Conti P, McEwan AJ, Pomper MG. Molecular imaging: the future of modern medicine. J Nucl Med. 2008 Jun; 49(6):16N-20N. PMID: 18511813.
        View in: PubMed
      95. Jadvar H, Gurbuz A, Li X, Shahinian A, Conti P. Choline autoradiography of human prostate cancer xenograft: effect of castration. Mol Imaging. 2008 May-Jun; 7(3):147-52. PMID: 19123985.
        View in: PubMed
      96. Jadvar H, Quan V, Henderson RW, Conti P. [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma. Int J Clin Oncol. 2008 Feb; 13(1):42-7. PMID: 18307018.
        View in: PubMed
      97. Ulaner GA, Colletti PM, Conti P. B-cell non-Hodgkin lymphoma: PET/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy--initial experience. Radiology. 2008 Mar; 246(3):895-902. PMID: 18258810.
        View in: PubMed
      98. Iagaru A, Masamed R, Chawla SP, Menendez LR, Fedenko A, Conti P. F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas. Clin Nucl Med. 2008 Jan; 33(1):8-13. PMID: 18097248.
        View in: PubMed
      99. Conti P, Bading JR, Mouton PP, Links JM, Alauddin MM, Fissekis JD, Ravert HT, Hilton J, Wong DF, Anderson JH. In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET. Nucl Med Biol. 2008 Jan; 35(1):131-41. PMID: 18158952.
        View in: PubMed
      100. Wiseman GA, Conti P, Vo K, Schilder RJ, Gordon LI, Emmanouilides C, Silverman DH, Witzig TE, Darif M, Molina A. Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Clin Lymphoma Myeloma. 2007 Sep; 7(8):514-7. PMID: 18021468.
        View in: PubMed
      101. Liao CP, Zhong C, Saribekyan G, Bading J, Park R, Conti P, Moats R, Berns A, Shi W, Zhou Z, Nikitin AY, Roy-Burman P. Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence. Cancer Res. 2007 Aug 1; 67(15):7525-33. PMID: 17671224.
        View in: PubMed
      102. Jadvar H, Henderson RW, Conti P. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma. J Comput Assist Tomogr. 2007 Mar-Apr; 31(2):223-8. PMID: 17414758.
        View in: PubMed
      103. Iagaru A, Masamed R, Singer PA, Conti P. Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET and PET/CT. Mol Imaging Biol. 2007 Mar-Apr; 9(2):72-7. PMID: 17186139.
        View in: PubMed
      104. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti P. Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives. Nucl Med Biol. 2007 Apr; 34(3):267-72. PMID: 17383576.
        View in: PubMed
      105. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti P. In vivo evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil ([18F]FIAU) and 2'-deoxy-2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging. 2007 Jun; 34(6):822-9. PMID: 17206416.
        View in: PubMed
      106. Iagaru A, Masamed R, Keesara S, Conti P. Breast MRI and 18F FDG PET/CT in the management of breast cancer. Ann Nucl Med. 2007 Jan; 21(1):33-8. PMID: 17373334.
        View in: PubMed
      107. Iagaru A, Chawla S, Menendez L, Conti P. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas. Nucl Med Commun. 2006 Oct; 27(10):795-802. PMID: 16969262.
        View in: PubMed
      108. Sodir NM, Chen X, Park R, Nickel AE, Conti P, Moats R, Bading JR, Shibata D, Laird PW. Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice. Cancer Res. 2006 Sep 1; 66(17):8430-8. PMID: 16951153.
        View in: PubMed
      109. Iagaru A, Masamed R, Singer PA, Conti P. 2-Deoxy-2-[18F]fluoro-D-glucose-positron emission tomography and positron emission tomography/computed tomography diagnosis of patients with recurrent papillary thyroid cancer. Mol Imaging Biol. 2006 Sep-Oct; 8(5):309-14. PMID: 16758370.
        View in: PubMed
      110. Jadvar H, Henderson RW, Conti P. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer. Mol Imaging Biol. 2006 May-Jun; 8(3):193-200. PMID: 16565910.
        View in: PubMed
      111. Chen X, Park R, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Moats RA, Bading JR, Laug WE, Conti P. Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide. Mol Imaging Biol. 2006 Jan-Feb; 8(1):9-15. PMID: 16315003.
        View in: PubMed
      112. Chaudhari AJ, Darvas F, Bading JR, Moats RA, Conti P, Smith DJ, Cherry SR, Leahy RM. Hyperspectral and multispectral bioluminescence optical tomography for small animal imaging. Phys Med Biol. 2005 Dec 7; 50(23):5421-41. PMID: 16306643.
        View in: PubMed
      113. Conti P, White C, Pieslor P, Molina A, Aussie J, Foster P. The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry. J Nucl Med. 2005 Nov; 46(11):1812-8. PMID: 16269594.
        View in: PubMed
      114. Coleman RE, Delbeke D, Guiberteau MJ, Conti P, Royal HD, Weinreb JC, Siegel BA, Federle MF, Townsend DW, Berland LL. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Nucl Med. 2005 Jul; 46(7):1225-39. PMID: 16000293.
        View in: PubMed
      115. Coleman RE, Delbeke D, Guiberteau MJ, Conti P, Royal HD, Weinreb JC, Siegel BA, Federle MP, Townsend DW, Berland LL. Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. J Am Coll Radiol. 2005 Jul; 2(7):568-84. PMID: 17411882.
        View in: PubMed
      116. Jadvar H, Xiankui L, Shahinian A, Park R, Tohme M, Pinski J, Conti P. Glucose metabolism of human prostate cancer mouse xenografts. Mol Imaging. 2005 Apr-Jun; 4(2):91-7. PMID: 16105512.
        View in: PubMed
      117. Chen X, Sievers E, Hou Y, Park R, Tohme M, Bart R, Bremner R, Bading JR, Conti P. Integrin alpha v beta 3-targeted imaging of lung cancer. Neoplasia. 2005 Mar; 7(3):271-9. PMID: 15799827.
        View in: PubMed
      118. Conti P. The future of radioimmunotherapy: a PET perspective. Semin Oncol. 2005 Feb; 32(1 Suppl 1):S63-7. PMID: 15786028.
        View in: PubMed
      119. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti P. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. J Nucl Med. 2004 Dec; 45(12):2063-9. PMID: 15585483.
        View in: PubMed
      120. Cham D, Henderson R, Conti P. Virchow's node on F-18 FDG PET/CT. Clin Nucl Med. 2004 Nov; 29(11):770-2. PMID: 15483511.
        View in: PubMed
      121. Chen X, Conti P, Moats RA. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res. 2004 Nov 1; 64(21):8009-14. PMID: 15520209.
        View in: PubMed
      122. Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti P. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. J Nucl Med. 2004 Oct; 45(10):1776-83. PMID: 15471848.
        View in: PubMed
      123. Jadvar H, Gamie S, Ramanna L, Conti P. Musculoskeletal system. Semin Nucl Med. 2004 Oct; 34(4):254-61. PMID: 15493003.
        View in: PubMed
      124. Jadvar H, Conti P. The reproductive tract. Semin Nucl Med. 2004 Oct; 34(4):262-73. PMID: 15493004.
        View in: PubMed
      125. Chen X, Liu S, Hou Y, Tohme M, Park R, Bading JR, Conti P. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides. Mol Imaging Biol. 2004 Sep-Oct; 6(5):350-9. PMID: 15380745.
        View in: PubMed
      126. Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti P. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts. J Nucl Med. 2004 Aug; 45(8):1390-7. PMID: 15299066.
        View in: PubMed
      127. Bading JR, Shahinian AH, Vail A, Bathija P, Koszalka GW, Koda RT, Alauddin MM, Fissekis JD, Conti P. Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats. Nucl Med Biol. 2004 May; 31(4):407-18. PMID: 15093810.
        View in: PubMed
      128. Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti P. Synthesis of 2'-deoxy-2'-[18F]fluoro-5-bromo-1-beta-D-arabinofuranosyluracil ([18F]-FBAU) and 2'-deoxy-2'-[18F]fluoro-5-chloro-1-beta-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression. Nucl Med Biol. 2004 May; 31(4):399-405. PMID: 15093809.
        View in: PubMed
      129. Chen X, Park R, Hou Y, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Bading JR, Laug WE, Conti P. MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide. Eur J Nucl Med Mol Imaging. 2004 Aug; 31(8):1081-9. PMID: 15118844.
        View in: PubMed
      130. Chen X, Tohme M, Park R, Hou Y, Bading JR, Conti P. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide. Mol Imaging. 2004 Apr; 3(2):96-104. PMID: 15296674.
        View in: PubMed
      131. Alauddin MM, Shahinian A, Gordon EM, Conti P. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol Imaging. 2004 Apr; 3(2):76-84. PMID: 15296672.
        View in: PubMed
      132. Chen X, Park R, Shahinian AH, Tohme M, Khankaldyyan V, Bozorgzadeh MH, Bading JR, Moats R, Laug WE, Conti P. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol. 2004 Feb; 31(2):179-89. PMID: 15013483.
        View in: PubMed
      133. Chen X, Park R, Shahinian AH, Bading JR, Conti P. Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation. Nucl Med Biol. 2004 Jan; 31(1):11-9. PMID: 14741566.
        View in: PubMed
      134. Chen X, Park R, Tohme M, Shahinian AH, Bading JR, Conti P. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. Bioconjug Chem. 2004 Jan-Feb; 15(1):41-9. PMID: 14733582.
        View in: PubMed
      135. Conti P. Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician. Semin Nucl Med. 2004 Jan; 34(1 Suppl 1):2-3. PMID: 14762737.
        View in: PubMed
      136. Jadvar H, Pinski JK, Conti P. FDG PET in suspected recurrent and metastatic prostate cancer. Oncol Rep. 2003 Sep-Oct; 10(5):1485-8. PMID: 12883728.
        View in: PubMed
      137. Bading JR, Yoo PB, Fissekis JD, Alauddin MM, D'Argenio DZ, Conti P. Kinetic modeling of 5-fluorouracil anabolism in colorectal adenocarcinoma: a positron emission tomography study in rats. Cancer Res. 2003 Jul 1; 63(13):3667-74. PMID: 12839957.
        View in: PubMed
      138. Alauddin MM, Louie AY, Shahinian A, Meade TJ, Conti P. Receptor mediated uptake of a radiolabeled contrast agent sensitive to beta-galactosidase activity. Nucl Med Biol. 2003 Apr; 30(3):261-5. PMID: 12745017.
        View in: PubMed
      139. Jadvar H, Conti P. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol. 2002 Dec; 31(12):690-4. PMID: 12483429.
        View in: PubMed
      140. Tatlidil R, Jadvar H, Bading JR, Conti P. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002 Sep; 224(3):783-7. PMID: 12202714.
        View in: PubMed
      141. Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Finn R, Bornmann W, Thaler H, Conti P, Blasberg RG. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J Nucl Med. 2002 Aug; 43(8):1072-83. PMID: 12163634.
        View in: PubMed
      142. Alauddin MM, Shahinian A, Gordon EM, Conti P. Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo. Mol Imaging. 2002 Apr-Jun; 1(2):74-81. PMID: 12920847.
        View in: PubMed
      143. Wagner HN, Wiseman GA, Marcus CS, Nabi HA, Nagle CE, Fink-Bennett DM, Lamonica DM, Conti P. Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with (90)Y-labeled anti-CD20 monoclonal antibody. J Nucl Med. 2002 Feb; 43(2):267-72. PMID: 11850494.
        View in: PubMed